Company news
Inoviq Ltd (ASX:IIQ) news
Inoviq Ltd news releases on 6ix. Latest, Jun 19, 2018: Improved Performance of BARD1 Ovarian Test
Press releases — page 4
Improved Performance of BARD1 Ovarian Test
June 19, 2018
Contract Development Agreement Signed
May 18, 2018
Voluntary Suspension
May 14, 2018
Capital Raising
March 21, 2018
Israeli Patent Issued in Bard1 Core Patent Family
March 20, 2018
Additional BARD1 Ovarian Test Results
March 5, 2018
Grant of Japanese Patent
February 1, 2018
RESULTS OF BARD1 OVARIAN CANCER STUDY
January 9, 2018
Research and Development Update
October 4, 2017
Appendix 4E Preliminary Financial Results
August 31, 2017
Publication of BARD1 Lung Cancer Test
August 7, 2017
Australian Patent Issued
August 6, 2017
Shareholder Update
June 28, 2017
Lung Cancer Study Results
May 14, 2017
Cancer Vaccine Collaboration
April 4, 2017
OVARIAN CANCER CLINICAL STUDY RESULTS
March 22, 2017
Appendix 4D and Half Yearly Reports and Accounts
February 28, 2017
Successful Assay Feasibility Results
February 8, 2017
Quarterly Activities Review and Appendix 4C
January 30, 2017
Appointment of CEO
November 3, 2016
Company Update - Promising Result for Ovarian Cancer
September 22, 2016
Preliminary Final Report - Appendix 4E
August 31, 2016
Reinstatement to Official Quotation - 20 June 2016
June 17, 2016
Suspension from Official Quotation
February 11, 2016
Company Update
February 10, 2016